CPRX Catalyst Pharmaceuticals Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
16:21
Apr 27
Apr 27
Reports additional M&A activity for Catalyst Pharmaceuticals, no directional view stated.
HIGH
19:50
Feb 08
Feb 08
* CALM: Correction appears finished. * VITL: Forming a flat transition pattern. * CPRX: Trading near highs ($26.50) with strong fundamentals (low P/E, growing revenue). These are specific idiosyncratic setups unrelated to the broader tech beta. CPRX specifically is a breakout candidate if it clears resistance. Long (Tactical). Low liquidity in smaller caps; specific industry risks (e.g., avian flu for CALM).
18:48
Jan 20
Jan 20
Bullish small-cap pharma on growth and AGAMREE
The author owns a sizable position in Catalyst Pharmaceuticals and likes it as a medium-term hold, citing high cash with no debt enabling buybacks, high gross/net margins, strong YoY revenue growth (492M in 2024, ~565-585M in 2025), a low ~13 P/E, and ROE/ROIC/ROA of 35-38%/35-36%/22-23%. The newly approved drug AGAMREE is a growth catalyst. Main stated risks are that the core drug Firdapse faces lawsuits and FDA issues, revenue is capped by very niche drugs, and as a small-cap pharma it is subject to investor sentiment.
HIGH
01:07
Jan 14
Jan 14
Like Catalyst Pharmaceuticals on cheap earnings
Likes Catalyst Pharmaceuticals because it has real earnings and is a very inexpensive stock; if you have a winner, stick with it.
MED
00:52
Jan 14
Jan 14
Catalyst is cheap with real earnings.
Cramer likes Catalyst Pharmaceuticals because it has real earnings and the stock is very inexpensive; he calls it a winner.
MED
About CPRX Investor Commentary
Across the available history and selected sources, Buzzberg tracks CPRX (Catalyst Pharmaceuticals Inc.) across 4 sources: 4 bullish vs 0 bearish calls from 4 authors. Historical directional balance: 80% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 5 total trade ideas tracked. Latest voices: seedy19tron, Dmitry Solodin, u/Ultpanchu.